OM:HEXA B
OM:HEXA BElectronic

Hexagon (OM:HEXA B): Evaluating Fair Value After Profits Slide in Latest Earnings Release

Hexagon (OM:HEXA B) released its third-quarter earnings, showing stable revenue but a swing to a net loss and a sharp year-on-year drop in nine-month profits. This shift in profitability is drawing investor attention. See our latest analysis for Hexagon. While Hexagon’s revenue has held steady, the recent dip into a quarterly net loss and falling profits have led to some volatility. However, the market appears mostly resilient. The share price has logged a healthy 6.4% return over the past...
OM:NYF
OM:NYFReal Estate

Will Nyfosa's (OM:NYF) Return to Profitability on Lower Revenues Shift Its Investment Narrative?

Nyfosa recently reported third quarter earnings for 2025, revealing SEK 887 million in revenue and net income of SEK 295 million, compared to a net loss in the same period last year. This marks a turnaround in profitability for the company, achieved even as sales and revenues were slightly lower than the prior-year period. We'll explore how Nyfosa's return to profitability amid softer revenues could impact the company's overall investment narrative. AI is about to change healthcare. These 34...
OM:MSAB B
OM:MSAB BSoftware

Micro Systemation (OM:MSAB B) Earnings Surge 204%, Reinforcing Bullish Growth Narratives

Micro Systemation (OM:MSAB B) delivered annual earnings growth of 204.3% in the latest year, significantly ahead of its 5-year average of 7.1%. Net profit margin improved to 9.6% from last year’s 3.4%. Ongoing growth prospects also remain strong, with revenue forecast to rise 10% per year and earnings expected to grow 26% per year for the next three years. See our full analysis for Micro Systemation. Now, let’s put these headline numbers side by side with the stories circulating in the market...
OM:ALFA
OM:ALFAMachinery

Alfa Laval (OM:ALFA) Profit Margin Beat Reinforces Bullish Valuation Narrative

Alfa Laval (OM:ALFA) posted a net profit margin of 12.1%, up from last year’s 10.4%, with earnings surging 21% over the past year, which is faster than the company’s five-year compound growth rate of 16.9%. With revenue expected to grow 4.9% per year and earnings projected to rise 5.2% annually, investors are weighing strong historical profit growth and favorable valuation signals against broader market growth rates and one flagged risk around dividend sustainability. See our full analysis...
OM:VIMIAN
OM:VIMIANMedical Equipment

Will Vimian Group's (OM:VIMIAN) Aggressive M&A Push Define Its Path to 2030 Ambitions?

Vimian Group AB reported third-quarter 2025 earnings, showing sales of €104.3 million and net income of €6.5 million, while also announcing plans to accelerate its mergers and acquisitions (M&A) strategy as a key pillar of growth in the global animal health space. An important insight is the company's reaffirmed commitment to using M&A alongside organic growth to achieve its long-term goal of reaching €300 million in earnings by 2030, guided by strong financial discipline and a clear...
OM:SEB A
OM:SEB ABanks

Evaluating SEB’s (OM:SEB A) Valuation After Strong Share Price Gains This Year

Skandinaviska Enskilda Banken (OM:SEB A) shares have shown a mixed performance lately, with a small pullback in the past month but solid gains year to date. Investors might be weighing recent valuation trends. See our latest analysis for Skandinaviska Enskilda Banken. SEB’s share price has climbed more than 19% year-to-date, giving investors plenty to cheer about. The real story has been the bank’s robust long-term momentum, with a one-year total shareholder return of 27% and an impressive...